itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of Veeco Instruments Fall to a Ne...

Veeco Instruments (NASDAQ:VECO) traded today at a new 52-week low of $25.28. This new ...

Watch for Continued Losses in Shares of ...

Unit Corp (NYSE:UNT) traded at a new 52-week low today of $19.01. So far today approxi ...

Watch for Continued Gains in Shares of U...

Shares of Unilever (NYSE:UN) traded at a new 52-week high today of $45.88. Approximate ...

Shares of Unilever Have Risen Above Prev...

Shares of Unilever (NYSE:UL) traded at a new 52-week high today of $45.98. This new hi ...

Shares of Unisys Fall Below Previous 52-...

Unisys (NYSE:UIS) traded at a new 52-week low today of $15.56. So far today approximat ...

Net 1 UEPS Technologies Looks to Continu...

Net 1 UEPS Technologies (NASDAQ:UEPS) traded at a new 52-week high today of $20.37. Ap ...

UBS Looks to Continue to Trade Above its...

UBS (NYSE:UBS) traded today at a new 52-week high of $23.19. Approximately 1.9 million ...

Shares of Texas Roadhouse Rise Above Pre...

Shares of Texas Roadhouse (NASDAQ:TXRH) traded today at $40.22, breaking its 52-week hi ...

Most Popular Video News